Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Learn which credit cards offer no annual fee along with bonus rewards. Make an informed choice for your finances!
28,655 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
When a founder sells a sizable stake, investors take note. This article digs into the implications of airbnb co-found...
Garmin delivered a dominant Q4 with a big EPS beat and revenue surge, triggering a sharp market rally as investors we...
Bittensor TAO jumped close to 18% over a short window, signaling renewed momentum in AI-focused crypto. This article ...
Lemonade's shares swung wildly in a single session, rising on an earnings beat and then tumbling as expectations cool...
Meme coins linked to a president jumped on headlines about alien disclosure, led by the TRUMP token. The move faded a...
Restaurant chains are moving from dialogue to action to fix toxic work culture. Early pilots show improved morale and...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
Goldman Sachs updated its governance policy to remove formal DEI criteria from director selection, aligning with peer...
Anywhere Real Estate gains preliminary approval for the Tuccori settlement amid a denial of the Batton plaintiffs' bi...
A fintech platform unveils AI-driven index construction from a single prompt, with an uncapped 1% match for new membe...
Bitcoin remains in focus as investors weigh new geopolitical flare-ups. Markets are pricing risk as bitcoin (and peac...